Sign in

CIK 0001020214 · Accelerated filer

CERUS CORP

Sign in to watch
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
680262011
Phone
9252886000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  2. 4 Grant or award Chief Legal Officer acquired 200,000 shares (grant or award)
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 4 Planned sale Chief Legal Officer sold 113,008 shares at $1.66 ($187,277)
  6. 4 Planned sale Chief Operating Officer sold 165,200 shares at $1.66 ($273,769)
  7. 4 Planned sale President and CEO sold 447,757 shares at $1.66 ($742,023)
  8. 4 Planned sale Chief Financial Officer sold 127,544 shares at $1.66 ($211,366)
  9. 4 Planned sale Chief Medical Officer sold 101,740 shares at $1.66 ($168,604)
  10. 8-K Event Executive or director change
  11. 4/A Planned sale Chief Medical Officer sold 125,894 shares at an average $1.99 ($250,932)
  12. 4 Planned sale Chief Financial Officer sold 83,021 shares at an average $2.04 ($169,646)
  13. 4 Planned sale Chief Medical Officer sold 125,894 shares at an average $1.99 ($250,938)
  14. 4 Planned sale Chief Legal Officer sold 30,845 shares at $2.01 ($61,860)
  15. 4 Planned sale Chief Operating Officer sold 34,094 shares at $2.01 ($68,376)
  16. 4 Planned sale President and CEO sold 78,187 shares at $2.01 ($156,804)
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 4 Grant or award Chief Medical Officer acquired 264,000 shares (grant or award)

Page 3 of 76 · 1,513 filings